Invests in Belgium’s Frid Mind Technologies to advance stroke prevention

Biorad Medisys outlined a series of product development initiatives and investments in the neurovascular and peripheral vascular markets. 

Biorad has invested in Frid Mind Technologies (FMT), a Belgium-based company founded by
Noureddine Frid. FMT has developed a [patented stroke-prevention product using advanced
braiding technology]. The technology has completed preclinical trials and two first-in-human cases
with positive long-term follow-up. 

In addition, Biorad has acquired 10 per cent stake in Motion Informatics (formerly Stroke Rehab),
an Israel-based company specialising in stroke rehabilitation solutions. Motion Informatics
manufactures and markets the US FDA-approved Stimel-03 device, which integrates NMES, FES, and
Biofeedback technologies to support patient rehabilitation. Biorad also holds manufacturing and
distribution rights for the device in select geographies, including India and the US. 

JM Hegde, MD, Biorad Medisys, said, “Our collaborations with [FMT] and Motion Informatics, together with our work in advanced braiding technologies, reflect our ongoing efforts in the field of vascular and stroke care.”